1 | Provisional Agenda | 21/09/2015 | | CX/NFSDU 16/38/1 |
8 | Proposed draft Guideline for Ready-to-use Therapeutic Foods | 26/07/2016 | | CX/NFSDU 16/38/9 |
6 | Proposed draft Definition for Biofortification | 01/08/2016 | | CX/NFSDU 16/38/7 |
7 | Proposed Draft NRV-NCD for EPA and DHA Long Chain Omega-3 Fatty Acids | 17/08/2016 | | CX/NFSDU 16/38/8 |
5 | Review of the Standard for Follow-Up Formula
(CODEX STAN 156-1987) | 12/09/2016 | | CX/NFSDU 16/38/6 |
4.1 | Draft NRV-R for Vitamin E (comments at Step 6) | 13/10/2016 | | CX/NFSDU 16/38/4 |
8.1 | Proposed Draft Guideline for Ready-to-use Therapeutic Foods (comments at Step 3) | 13/10/2016 | | CX/NFSDU 16/38/9 Add.1 |
6.1 | Proposed Draft Definition for Biofortification (comments at Step 3) | 17/10/2016 | | CX/NFSDU 16/38/7-Add.1 |
9 | Discussion paper on claim for "free" of trans fatty acids | 01/11/2016 | | CX/NSDU 16/38/10 |
4.2 | Proposed draft Additional or Revised Nutrient Reference Values for Labelling Purposes in the Guidelines on Nutrition Labelling (Vitamin D and the dietary equivalents and conversion factor for Vitamin E) (comments at Step 3) | 02/11/2016 | | CX/NFSDU 16/38/5 |
7.1 | Proposed draft NRV-NCD for EPA and DHA long chain omega-3 fatty acids (comments at Step 3) | 02/11/2016 | | CX/NFSDU16/38/8-Add.1 |
2 | Matters Referred by the Codex Alimentarius Commission and/or Other Subsidiary Bodies | 03/11/2016 | | CX/NFSDU 16/38/2 |
10 | Alignment of food additive provisions in standards developed by CCNFSDU | 08/11/2016 | | CX/NFSDU 16/38/11 |
11 | Other business and future work - Methods of analysis in the Standard for Infant Formula and Formulas for Special Medical Purposes Intended for Infants (CODEX STAN 72-1981 | 09/11/2016 | | CX/NFSDU 16/38/12 |
5.1 | Review of the Standard for Follow-up Formula (CODEX STAN 156-1987) (comments at Step 3) | 15/11/2016 | | CX/NFSDU 16/38/6 Add.1 |
3 | Matters of Interest Arising from FAO and WHO | 25/11/2016 | | CX/NFSDU 16/38/3 |
100 | Division of Competence between the European Union and its Member States | 12/08/2016 | | CRD1 |
102 | Review of the Standard for Follow-up Formula (CODEX STAN 156-1987) - Physical Working Group Report | 12/04/2016 | | CRD2 |
| Report | 15/05/2017 | | REP17/NFSDU |
0.1 | Information for delegates | 11/07/2016 | | |
6.2 | Proposed Draft Definition for Biofortification (comments at Step 3) | 17/11/2016 | | CX/NFSDU 16/38/7 Add.2 |
7.2 | Proposed draft NRV-NCD for EPA and DHA Long Chain Omega-3 fatty acids (comments at Step 3) | 17/11/2016 | | CX/NFSDU 16/38/8 Add.2 |
8.2 | Proposed Draft Guideline for Ready-to-Use Therapeutic Foods (comments at Step 3) | 17/11/2016 | | CX/NFSDU 16/38/9 Add.2 |
5.2 | Review of the Standard for Follow-up Formula (CODEX STAN 156-1987) (comments at Step 3) | 28/11/2016 | | CX/NFSDU16/38/6 Add.2 |
103 | Review of the standard for follow-up formula: comments of India, Indonesia, Kenya, Nigeria, African Union (Agenda 5) | 03/12/2016 | | CRD3 |
104 | Matters referred to the committee by the Codex Alimentarius Commission and/or other subsidiary bodies - Comments of European Union, Kenya, African Union, IDF and ISDI (Agenda 2) | 04/12/2016 | | CRD4 |
105 | Draft NRV-R for vitamin E - Comments of India, Malaysia, Mexico, Peru and the African Union (Agenda 4a) | 04/12/2016 | | CRD5 |
106 | Proposed draft additional or revised nutrient reference values for labelling (Vitamin D and the dietary equivalents and conversion factor for Vitamin E) - Comments of India, Indonesia, Malaysia, African Union, NHF (Agenda 4b) | 04/12/2016 | | CRD6 |
107 | Proposed draft definition for Biofortification - Comments of Ecuador, European Union. India, Nigeria, Peru, Thailand and the African Union (Agenda 6) | 04/12/2016 | | CRD7 |
108 | Proposed draft NRV-NCD for EPA and DHA long chain Omega-3 fatty acids - Comments of Ecuador, the European Union, Peru, Thailand and the African Union (Agenda 7) | 04/12/2016 | | CRD8 |
109 | Proposed Draft Guideline for Ready-to-use Therapeutic Foods - Comments of Ecuador, El Salvador, European Union, India, Kenya, Mexico, Nigeria, Thailand, African Union and FEDIOL (Agenda 8) | 04/12/2016 | | CRD9 |
110 | Discussion paper on claim for “free” of trans fatty acids - Comments of India, Indonesia, Kenya, Malaysia, Nigeria, United States of America, African Union, IDF and IFMA (Agenda 9) | 04/12/2016 | | CRD10 |
111 | Alignment of food additive provisions in standards developed by CCNFSDU - Comments of Nigeria, Thailand, African Union, IFMA and ISDI (Agenda 10) | 04/12/2016 | | CRD11 |
112 | Other business and future work - Comments of Mexico, Nigeria, Thailand, African Union and ISDI (Agenda 11) | 04/12/2016 | | CRD12 |
102.1 | Review of the Standard For Follow-Up Formula (CODEX STAN 156-1987) - Physical Working Group Report (Recommendation 11 – protein quality) | 05/12/2016 | | CRD13 |
113 | Comments of Benin | 05/12/2016 | | CRD14 |
114 | Comments of Chile, Mexico, ESPGHAN | 05/12/2016 | | CRD15 |
115 | Comments of Republic of Korea | 05/12/2016 | | CRD16 |
102.2 | PWG Side Session report: Modelling Macronutrient Levels | 05/12/2016 | | CRD17 |
116 | Methods of analysis for provisions in the standard for infant formula and formulas for special medical purposes intended for infants - PWG Side Session report: recommendations to the Committee | 06/12/2016 | | CRD18 |
117 | All files zip collection | | | |